Chemoinformaics analysis of (+)-Abscissic-Acid
Molecular Weight | 292.375 | nRot | 4 |
Heavy Atom Molecular Weight | 268.183 | nRig | 10 |
Exact Molecular Weight | 292.167 | nRing | 1 |
Solubility: LogS | -2.931 | nHRing | 0 |
Solubility: LogP | 2.945 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 47.601 |
nHD | 1 | BPOL | 27.549 |
QED | 0.491 |
Synth | 3.688 |
Natural Product Likeliness | 2.304 |
NR-PPAR-gamma | 0.121 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.722 |
Pgp-sub | 0.005 |
HIA | 0.01 |
CACO-2 | -4.656 |
MDCK | 0.0000364 |
BBB | 0.728 |
PPB | 0.847524 |
VDSS | 1.498 |
FU | 0.128765 |
CYP1A2-inh | 0.124 |
CYP1A2-sub | 0.396 |
CYP2c19-inh | 0.907 |
CYP2c19-sub | 0.828 |
CYP2c9-inh | 0.726 |
CYP2c9-sub | 0.161 |
CYP2d6-inh | 0.086 |
CYP2d6-sub | 0.131 |
CYP3a4-inh | 0.346 |
CYP3a4-sub | 0.74 |
CL | 6.548 |
T12 | 0.715 |
hERG | 0.036 |
Ames | 0.016 |
ROA | 0.501 |
SkinSen | 0.941 |
Carcinogencity | 0.573 |
EI | 0.092 |
Respiratory | 0.698 |
NR-Aromatase | 0.735 |
Antiviral | Yes |
Prediction | 0.686048 |